- Previous Close
20.60 - Open
20.70 - Bid 20.40 x --
- Ask 20.50 x --
- Day's Range
20.40 - 20.70 - 52 Week Range
20.40 - 27.75 - Volume
338,923 - Avg. Volume
963,837 - Market Cap (intraday)
5.974B - Beta (5Y Monthly) --
- PE Ratio (TTM)
11.15 - EPS (TTM)
1.83 - Earnings Date Feb 21, 2025 - Feb 25, 2025
- Forward Dividend & Yield 0.75 (3.64%)
- Ex-Dividend Date Dec 12, 2024
- 1y Target Est
26.50
Rajthanee Hospital Public Company Limited, together with its subsidiaries, engages in the provision of healthcare services in Thailand. The company operates medical centers, including trauma emergency and neurosurgery, non-trauma emergency, cardiology, minimally invasive surgery, surgery, orthopedic, wellness and occupational health, radiology, MRI, ophthalmology, hemodialysis, sleep lab, dental, physical therapy, and laboratory centers. It also operates medical clinics, such as hematology, nephrology, arthritis and rheumatic, dermatology, allergy and immunology, oncology and chemotherapy, stroke, endocrinology, pulmonary, gastrointestinal and liver diseases, pediatrics, maternal and fetal medicine, obstetrics and gynecology, otolaryngology, psychiatric, and screening clinic for respiratory diseases. The company was incorporated in 1990 and is based in Phra Nakhon Si Ayutthaya, Thailand.
www.rajthanee.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RJH.BK
View MorePerformance Overview: RJH.BK
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RJH.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RJH.BK
View MoreValuation Measures
Market Cap
6.03B
Enterprise Value
7.21B
Trailing P/E
11.26
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.25
Price/Book (mrq)
2.72
Enterprise Value/Revenue
2.63
Enterprise Value/EBITDA
8.76
Financial Highlights
Profitability and Income Statement
Profit Margin
19.70%
Return on Assets (ttm)
10.27%
Return on Equity (ttm)
22.36%
Revenue (ttm)
2.78B
Net Income Avi to Common (ttm)
546.94M
Diluted EPS (ttm)
1.83
Balance Sheet and Cash Flow
Total Cash (mrq)
177.36M
Total Debt/Equity (mrq)
53.86%
Levered Free Cash Flow (ttm)
-165.47M